MedTrace Logo

In Vitro Maturation of Human Eggs

NCT06633120 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-10-09

No results posted yet for this study

Summary

CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication

Conditions

  • Healthy
  • PCOS
  • PCOS (Polycystic Ovary Syndrome)
  • Ovarian Reserve
  • Infertility
  • Infertility Female
  • Infertility of Tubal Origin
  • Infertility Poly Cystic Ovary
  • AMH
  • In Vitro Maturation
  • IVM
  • IVF

Interventions

OTHER

IVM

Immature oocytes will be retrieved from small ovarian follicles and matured overnight in the laboratory prior to undergoing fertilization and embryo culture.

Sponsors & Collaborators

  • Colorado Center for Reproductive Medicine

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-03
Primary Completion
2029-07-31
Completion
2030-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06633120 on ClinicalTrials.gov